pmc logo imageJournal ListSearchpmc logo image
Logo of iaiInfect Immun SubscriptionsInfect Immun Web Site
Infect Immun. 1983 June; 40(3): 1204–1213.
PMCID: PMC348178
A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.
J Mizuno, J O Cisar, A E Vatter, P V Fennessey, and F C McIntire
Abstract
A highly specific aggregation factor for Streptococcus sanguis H1 (AFH1) was obtained by lysozyme treatment of Actinomyces viscosus T14V. At 1 micrograms/ml, AFH1 aggregated a suspension of S. sanguis H1, with which A. viscosus T14V coaggregates by a mechanism not inhibited by lactose: even at much higher levels AFH1 caused little or no aggregation of streptococci from other coaggregation groups (J. O. Cisar et al., Infect. Immun. 24:742-752, 1979). The most active fraction of AFH1 obtained by gel chromatography (near the void volume of Bio-Gel A1.5 m) reacted as a single antigen with anti-A. viscosus T14V serum and was unrelated to the fimbrial antigens of A. viscosus T14V. Smaller molecular fractions, at high levels, inhibited aggregation of S. sanguis H1 by high-molecular-weight AFH1 as well as coaggregation of S. sanguis H1 with A. viscosus T14V. The AFH1 fraction with high aggregating activity was composed of approximately 53% cell wall components (alanine, glutamine, lysine, N-acetylglucosamine, and N-acetylmuramic acid). 40% polysaccharide (N-acetylgalactosamine, rhamnose, and 6-deoxytalose), and 7% protein; teichoic acid was not detected. The fraction which inhibited aggregation and coaggregation contained much less of the cell wall constituents and more of the polysaccharide than the fraction with potent aggregating activity. Aggregation was completely prevented either by treating AFH1 with 0.01 M periodate at 25 degrees C for 4 h or by treating S. sanguis H1 with heat or pronase. A role for electrostatic forces in the aggregation was indicated by: (i) NaCl inhibition of aggregation, and (ii) a great decrease in aggregation potency as a result of chemical modification of either cationic or anionic groups of AFH1. On the other hand, NaCl reversed the aggregation only very weakly. The overall data suggest that a carbohydrate-protein interaction may be dominant in the aggregation of S. sanguis H1 by AFH1 and in the coaggregation of S. sanguis H1 with A. viscosus T14V.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • BARTLETT, GR. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed]
  • Bladen, H; Hageage, G; Pollock, F; Harr, R. Plaque formation in vitro on wires by gram-negative oral microorganisms (Veillonella). Arch Oral Biol. 1970 Feb;15(2):127–133. [PubMed]
  • Cisar, JO; Barsumian, EL; Curl, SH; Vatter, AE; Sandberg, AL; Siraganian, RP. Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies. J Immunol. 1981 Oct;127(4):1318–1322. [PubMed]
  • Cisar, JO; Kolenbrander, PE; McIntire, FC. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Infect Immun. 1979 Jun;24(3):742–752. [PubMed]
  • Cisar, JO; McIntire, FC; Vatter, AE. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34. Adv Exp Med Biol. 1978;107:695–701. [PubMed]
  • Cisar, JO; Vatter, AE. Surface fibrils (fimbriae) of Actinomyces viscosus T14V. Infect Immun. 1979 May;24(2):523–531. [PubMed]
  • Cisar, JO; Vatter, AE; McIntire, FC. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14. Infect Immun. 1978 Jan;19(1):312–319. [PubMed]
  • Gaugler, RW; Gabriel, O. Biological mechanisms involved in the formation of deoxy sugars. VII. Biosynthesis of 6-deoxy-L-talose. J Biol Chem. 1973 Sep 10;248(17):6041–6049. [PubMed]
  • Gibbons, RJ; Nygaard, M. Interbacterial aggregation of plaque bacteria. Arch Oral Biol. 1970 Dec;15(12):1397–1400. [PubMed]
  • Goodman, H; Pollock, JJ; Iacono, VJ; Wong, W; Shockman, GD. Peptidoglycan loss during hen egg white lysozyme-inorganic salt lysis of Streptococcus mutans. J Bacteriol. 1981 May;146(2):755–763. [PubMed]
  • Goodman, H; Pollock, JJ; Katona, LI; Iacono, VJ; Cho, MI; Thomas, E. Lysis of Streptococcus mutans by hen egg white lysozyme and inorganic sodium salts. J Bacteriol. 1981 May;146(2):764–774. [PubMed]
  • Habeeb, AF. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem. 1966 Mar;14(3):328–336. [PubMed]
  • Hammond, BF; Steel, CF; Peindl, KS. Antigens and surface components associated with virulence of Actinomyces viscosus. J Dent Res. 1976 Jan;55:A19–A25. [PubMed]
  • Kennedy, EP; Rumley, MK; Schulman, H; Van Golde, LM. Identification of sn-glycero-1-phosphate and phosphoethanolamine residues linked to the membrane-derived Oligosaccharides of Escherichia coli. J Biol Chem. 1976 Jul 25;251(14):4208–4213. [PubMed]
  • Kolenbrander, PE. Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis. Infect Immun. 1982 Sep;37(3):1200–1208. [PubMed]
  • Kolenbrander, PE; Williams, BL. Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis. Infect Immun. 1981 Jul;33(1):95–102. [PubMed]
  • MACLENNAN, AP. Composition of the cell wall of Actinomyces bovis: the isolation of 6-deoxy-L-talose. Biochim Biophys Acta. 1961 Apr 15;48:600–601. [PubMed]
  • McIntire, FC; Crosby, LK; Vatter, AE. Inhibitors of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34: beta-galactosides, related sugars, and anionic amphipathic compounds. Infect Immun. 1982 Apr;36(1):371–378. [PubMed]
  • McIntire, FC; Vatter, AE; Baros, J; Arnold, J. Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34. Infect Immun. 1978 Sep;21(3):978–988. [PubMed]
  • Ogata, S; Lloyd, KO. Mild alkaline borohydride treatment of glycoproteins-a method for liberating both N- and O-linked carbohydrate chains. Anal Biochem. 1982 Jan 15;119(2):351–359. [PubMed]
  • Revis, GJ; Vatter, AE; Crowle, AJ; Cisar, JO. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence. Infect Immun. 1982 Jun;36(3):1217–1222. [PubMed]
  • REYNOLDS, ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963 Apr;17:208–212. [PubMed]
  • SCHIFFMAN, G; KABAT, EA; THOMPSON, W. IMMUNOCHEMICAL STUDIES ON BLOOD GROUPS. XXX. CLEAVAGE OF A, B, AND H BLOOD-GROUP SUBSTANCES BY ALKALI. Biochemistry. 1964 Jan;3:113–120. [PubMed]
  • Tortosa, M; Cho, MI; Wilkens, TJ; Iacono, VJ; Pollock, JJ. Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva. Infect Immun. 1981 Jun;32(3):1261–1273. [PubMed]
  • Tylenda, CA; Charon, D; Lombardi, FP, Jr; Gabriel, O. Model studies on dental plaque formation: deoxyhexoses in Actinomyces viscosus. Infect Immun. 1979 Feb;23(2):312–319. [PubMed]